Overview
IBA RadioPharma Solutions offers integrated solutions for setting up radiopharmaceuticals production centers, including cyclotrons (Cyclone® series), radiochemistry systems (NEPTIS® and CASSY®), and turnkey facilities through IntegraLab®. The company provides services including upgrades, training through IBA Academy, and production support via Kare Portal.
Org chart
In the news
- 𝐍𝐞𝐱𝐭 𝐋𝐢𝐯𝐞 𝐈𝐁𝐀 𝐖𝐞𝐛𝐢𝐧𝐚𝐫, 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐚𝐤𝐞𝐫𝐬 Let us introduce the renowned experts in the field who will share their insights during our next live webinar: Health Technology Assessment in Nuclear Medicine: From Evidence Generation to Patient Access. 🎙️Health technology assessment in nuclear medicine: Challenges and opportunities in Europe, by Prof Dr Nadia Withofs, Nuclear Medicine Physician 🏢Institut de Cancérologie Arsène Burny (ICAB), CHU de Liège, Belgium 🎙️Health economics: From Clinical
- Thank you for visiting us at EANM 2026! Four days with one new chapter for IBA & ORA radiochemistry revealed with NEPTIS® Perform Duo, numerous demonstrations of the new cyclotron Cyclone® iKure capabilities, thousands of conversations, and a lot of coffee later. We thank you, to everyone who stopped by our booth during this congress. Let’s keep the momentum going; our team is here to support your next steps. 👉https://lnkd.in/eJkNH5_G #EANM2026 #radiopharmaceuticals #cyclotron #targetedalphatherapy #CycloneiKure #NEPTIS
- 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐩𝐞𝐧 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐈𝐁𝐀 𝐥𝐢𝐯𝐞 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐨𝐧 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 (𝐇𝐓𝐀) 𝐢𝐧 𝐧𝐮𝐜𝐥𝐞𝐚𝐫 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞, featuring renowned speakers, with Prof Dr Nadia Withofs, Prof Dr Lieven Annemans and Dr Konrade von Bremen. The session will be moderated by Cristiana Gameiro, PhD, IBA Fellow and Domain Expert in radiochemistry, and be followed by a live Q&A session with the experts. 👉 𝐒𝐚𝐯𝐞 𝐲𝐨𝐮𝐫
- Nuclear Medicine in Belgium 2026 – The energy, the ideas, the connections. Relive it all! One day. Inspiring discussions. Meaningful connections. One shared ambition. One week ago in Namur, BioWin brought together Belgian and international experts from industry, research, healthcare and regulatory authorities to connect expertise, foster collaboration and shape the future of nuclear medicine. 🚀 💡 From insightful discussions to new opportunities for collaboration, this event highlighted the strength of Belgium's ecosystem and
- 𝐌𝐞𝐞𝐭 𝐍𝐄𝐏𝐓𝐈𝐒® 𝐏𝐞𝐫𝐟𝐨𝐫𝐦 𝐃𝐮𝐨, the new IBA synthesizer module from tracer development to routine production. ✅ Built by the team behind NEPTIS® with 20 years of radiochemistry expertise, NEPTIS® Perform Duo brings both steps onto one module. ✅ For development, it uses reusable components, reused more than 30 times in internal testing, which lowers consumable costs. ✅ For production, it runs the same single-use cassettes and chemistries as NEPTIS® Perform, including FDG, the most widely used PET tracer. ✅ Two modes
- 𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐍𝐞𝐰𝐬! 𝐄𝐤𝐚𝐥𝐢𝐚 𝐭𝐚𝐤𝐞𝐬 𝐚𝐧 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐬𝐭𝐞𝐩 𝐢𝐧 𝐭𝐡𝐞 𝐝𝐞𝐩𝐥𝐨𝐲𝐦𝐞𝐧𝐭 𝐨𝐟 𝐀𝐬𝐭𝐚𝐭𝐢𝐧𝐞-𝟐𝟏𝟏 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐚 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐚𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 𝐰𝐢𝐭𝐡 𝐓𝐞𝐥𝐢𝐱. Ekalia, the joint venture combining IBA’s technological expertise with Framatome’s industrial know-how, has entered into a collaboration agreement with Telix Pharmaceuticals Limited, a global leader in radiopharmaceuticals, aimed at accelerating the
- 𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐍𝐞𝐰𝐬! 𝐈𝐁𝐀 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐍𝐄𝐏𝐓𝐈𝐒® 𝐏𝐞𝐫𝐟𝐨𝐫𝐦 𝐃𝐮𝐨, 𝐨𝐧𝐞 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐳𝐞𝐫 𝐦𝐨𝐝𝐮𝐥𝐞 𝐟𝐫𝐨𝐦 𝐭𝐫𝐚𝐜𝐞𝐫 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐨𝐮𝐭𝐢𝐧𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧. IBA today announces it has unveiled NEPTIS® Perform Duo, a synthesizer that lets radiopharmaceutical producers develop new tracers and manufacture them on one module, on October 18 at the EANM'26 Congress in Vienna, Austria. Developing a new PET imaging agent, known as a tracer, takes many trial runs. On most
- 𝐁𝐞 𝐭𝐡𝐞𝐫𝐞 𝐚𝐭 𝐈𝐁𝐀 𝐛𝐨𝐨𝐭𝐡 𝐚𝐭 𝐄𝐀𝐍𝐌 – 𝟐 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐦𝐨𝐦𝐞𝐧𝐭𝐬 𝐭𝐨𝐝𝐚𝐲! 🚀 Today at 11.00 am - 12.00 pm Discover Cyclone® iKure with the virtual tour, driven by our experts, Jean-Michel Geets, Vincent Petry. 🚀 Today at 2.45 pm A new radiochemistry era starts today! Be the first to see the latest innovation developed by the team behind NEPTIS® during the reveal. 📍 IBA booth 413 Let's connect with people. Let's drive the future. #EANM2026 #radiopharmaceuticals #cyclotron #targetedalphatherapy
Alumni
Anthony ToffoloR&D Requirement and Compliance Engineer
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.